secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001193125-26-100436
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences restructures notes: adds conversion at $0.06/share, principal to $2.256M
--------------------------------------------------------------------------------

- Outstanding note principal increased 20% to $2,256,000; monthly redemption obligation eliminated.
- Added conversion feature at $0.06/share, initially convertible into 37.6M shares of common stock.
- True-up provision requires additional note if net proceeds from conversion sales fall short of principal.
- Company paid $15,000 documentation fee; beneficial ownership cap set at 4.99% (can be raised to 9.99%).
- Management says restructuring strengthens balance sheet and positions for sustained profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000119312526100436/0001193125-26-100436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000119312526100436/cvsi-20260304.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-100436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer